Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke (Q66546837)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke |
clinical trial |
Statements
ACTION2 (English)
0 references
Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) in Acute Ischemic Stroke (English)
0 references
18 July 2016
0 references
20 November 2017
0 references
277
0 references
18 year
0 references
80 year
0 references